Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Weight-bearing MRI of the Lumbar Spine: Spinal Stenosis and Spondylolisthesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Weight-bearing MRI of the Lumbar Spine: Technical Aspects

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
To compare the efficacy of adalimumab, etanercept, and infliximab in patients with established rheumatoid arthritis (RA) taking concomitant methotrexate (MTX) by calculating the number needed to treat (NNT) using three different methods.
Original languageEnglish
JournalScandinavian Journal of Rheumatology
Volume36
Issue number6
Pages (from-to)411-7
Number of pages7
ISSN0300-9742
DOIs
Publication statusPublished - 2007

    Research areas

  • Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Rheumatoid, Drug Therapy, Combination, Humans, Immunoglobulin G, Patient Compliance, Questionnaires, Randomized Controlled Trials as Topic, Receptors, Tumor Necrosis Factor, Treatment Outcome

ID: 34769278